Study on the Hepatocellular Carcinoma Model with Metastasis

Overview

Journal Genes Dis

Date 2020 Sep 5

PMID 32884988

Citations 20

Authors

Yu-Lin Lin

Yan Li

Affiliations

Soon will be listed here.

Abstract

Hepatocellular carcinoma (HCC) is one of the most common causes of cancer-related death around the world due to advanced clinical stage at diagnosis, high incidence of recurrence and metastasis after surgical treatment. It is in urgent need to create appropriate animal models to explore the mechanism, patterns, risk factors, and therapeutic strategies of HCC metastasis and recurrence. However, most of the established models lack the phenotype of invasion and metastasis in patient, or have unstable phenotype. To establish HCC models with stable metastasis phenotype requires profound understanding in cancer metastasis biology and scientific methodology. Over the past 3 decades, HCC models with stable metastasis have been extensively studied. This paper reviewed the history and development of HCC animal models and cell models, focusing on the screening and maintaining of metastatic potential and phenotype. In-depth studies using these models vastly promote the understanding of cellular and molecular mechanisms and development of therapeutic strategies on HCC metastasis.

Citing Articles

3,4 Dihydroxyphenylethanol May Inhibit Metastasis in HepG2 Cells by Influencing the Expression of miR-21 and Genes Associated with Metastasis.

Alaee M, Shahsavari G, Yazdi M, Hormozi M Rep Biochem Mol Biol. 2025; 13(2):254-262.

PMID: 39995649 PMC: 11847581. DOI: 10.61186/rbmb.13.2.254.

Deciphering the synergistic role of tyrosyl-tRNA synthetase 1 and yes-associated protein 1: Catalysts of malignant progression in hepatocellular carcinoma.

Zhou L, Zhang X, Zhang C, Wang Y, Zhang J, Wang Y Cytojournal. 2025; 21:66.

PMID: 39917005 PMC: 11801646. DOI: 10.25259/Cytojournal_91_2024.

A Rare Case of Hepatocellular Carcinoma Presenting as Cervical Lymph Node Metastases and Review of the Literature.

Tkachuk B, Stukalin I, Wang Y, Congly S ACG Case Rep J. 2025; 12(2):e01620.

PMID: 39911373 PMC: 11798397. DOI: 10.14309/crj.0000000000001620.

The ncRNA-AURKA Interaction in Hepatocellular Carcinoma: Insights into Oncogenic Pathways, Therapeutic Opportunities, and Future Challenges.

Garcia C, Grisetti L, Tiribelli C, Pascut D Life (Basel). 2024; 14(11).

PMID: 39598228 PMC: 11595987. DOI: 10.3390/life14111430.

MicroRNAs in Hepatocellular Carcinoma: Insights into Regulatory Mechanisms, Clinical Significance, and Therapeutic Potential.

Guo F, Li H, Wang J, Wang J, Zhang J, Kong F Cancer Manag Res. 2024; 16:1491-1507.

PMID: 39450194 PMC: 11499618. DOI: 10.2147/CMAR.S477698.

References

Genda T, Sakamoto M, Ichida T, Asakura H, Kojiro M, Narumiya S . Cell motility mediated by rho and Rho-associated protein kinase plays a critical role in intrahepatic metastasis of human hepatocellular carcinoma. Hepatology. 1999; 30(4):1027-36. DOI: 10.1002/hep.510300420. View

Ye H, Zhang C, Wang B, Tan X, Zhang W, Teng Y . Synergistic function of Kras mutation and HBx in initiation and progression of hepatocellular carcinoma in mice. Oncogene. 2013; 33(43):5133-8. DOI: 10.1038/onc.2013.468. View

Soga M, Kishimoto Y, Kawamura Y, Inagaki S, Makino S, Saibara T . Spontaneous development of hepatocellular carcinomas in the FLS mice with hereditary fatty liver. Cancer Lett. 2003; 196(1):43-8. DOI: 10.1016/s0304-3835(03)00213-1. View

Aleksic K, Lackner C, Geigl J, Schwarz M, Auer M, Ulz P . Evolution of genomic instability in diethylnitrosamine-induced hepatocarcinogenesis in mice. Hepatology. 2011; 53(3):895-904. DOI: 10.1002/hep.24133. View

Heindryckx F, Colle I, Van Vlierberghe H . Experimental mouse models for hepatocellular carcinoma research. Int J Exp Pathol. 2009; 90(4):367-86. PMC: 2741148. DOI: 10.1111/j.1365-2613.2009.00656.x. View

Ip E, Farrell G, Hall P, Robertson G, Leclercq I . Administration of the potent PPARalpha agonist, Wy-14,643, reverses nutritional fibrosis and steatohepatitis in mice. Hepatology. 2004; 39(5):1286-96. DOI: 10.1002/hep.20170. View

Rygaard J . Immunobiology of the mouse mutant "Nude". Preliminary investigations. Acta Pathol Microbiol Scand. 1969; 77(4):761-2. View

Jin Y, Wang S, Chen W, Zhang J, Wang B, Guan H . Annexin A7 suppresses lymph node metastasis of hepatocarcinoma cells in a mouse model. BMC Cancer. 2013; 13:522. PMC: 3840638. DOI: 10.1186/1471-2407-13-522. View

Li Y, Tang Y, Ye L, Liu B, Liu K, Chen J . Establishment of a hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray. J Cancer Res Clin Oncol. 2003; 129(1):43-51. DOI: 10.1007/s00432-002-0396-4. View

10.

Fausto N, Campbell J . Mouse models of hepatocellular carcinoma. Semin Liver Dis. 2010; 30(1):87-98. DOI: 10.1055/s-0030-1247135. View

11.

Tian J, Tang Z, Ye S, Liu Y, Lin Z, Chen J . New human hepatocellular carcinoma (HCC) cell line with highly metastatic potential (MHCC97) and its expressions of the factors associated with metastasis. Br J Cancer. 1999; 81(5):814-21. PMC: 2374300. DOI: 10.1038/sj.bjc.6690769. View

12.

Sun J, Zhou X, Liu Y, Tang Z, Sun R, Zhao Y . Inhibitory effects of synthetic beta peptide on invasion and metastasis of liver cancer. J Cancer Res Clin Oncol. 2000; 126(10):595-600. DOI: 10.1007/pl00008470. View

13.

Yuki K, Hirohashi S, Sakamoto M, Kanai T, Shimosato Y . Growth and spread of hepatocellular carcinoma. A review of 240 consecutive autopsy cases. Cancer. 1990; 66(10):2174-9. DOI: 10.1002/1097-0142(19901115)66:10<2174::aid-cncr2820661022>3.0.co;2-a. View

14.

Zhao Y, Wei A, Chen X, Wang L, Zhang H, Yu X . α2,6-Sialylation mediates hepatocellular carcinoma growth in vitro and in vivo by targeting the Wnt/β-catenin pathway. Oncogenesis. 2017; 6(5):e343. PMC: 5523073. DOI: 10.1038/oncsis.2017.40. View

15.

Sawada S, Murakami K, Yamaura T, Mitani N, Tsukada K, Saiki I . Therapeutic and analysis model of intrahepatic metastasis reflects clinical behavior of hepatocellular carcinoma. Jpn J Cancer Res. 2002; 93(2):190-7. PMC: 5926959. DOI: 10.1111/j.1349-7006.2002.tb01258.x. View

16.

Masui T, Nakanishi H, Inada K, Imai T, Mizoguchi Y, Yada H . Highly metastatic hepatocellular carcinomas induced in male F344 rats treated with N-nitrosomorpholine in combination with other hepatocarcinogens show a high incidence of p53 gene mutations along with altered mRNA expression of tumor-related genes. Cancer Lett. 1997; 112(1):33-45. DOI: 10.1016/s0304-3835(96)04543-0. View

17.

Tan L, Chen S, Wei G, Li Y, Liao J, Jin H . Sublethal heat treatment of hepatocellular carcinoma promotes intrahepatic metastasis and stemness in a VEGFR1-dependent manner. Cancer Lett. 2019; 460:29-40. DOI: 10.1016/j.canlet.2019.05.041. View

18.

Liu Y, Ren W, Bai Y, Wan L, Sun X, Liu Y . Oxyresveratrol prevents murine H22 hepatocellular carcinoma growth and lymph node metastasis via inhibiting tumor angiogenesis and lymphangiogenesis. J Nat Med. 2018; 72(2):481-492. DOI: 10.1007/s11418-018-1173-2. View

19.

Reiberger T, Chen Y, Ramjiawan R, Hato T, Fan C, Samuel R . An orthotopic mouse model of hepatocellular carcinoma with underlying liver cirrhosis. Nat Protoc. 2015; 10(8):1264-74. PMC: 4800979. DOI: 10.1038/nprot.2015.080. View

20.

Chen L, Liu J, Yu X, He M, Pei X, Tang Z . The biocompatibility of quantum dot probes used for the targeted imaging of hepatocellular carcinoma metastasis. Biomaterials. 2008; 29(31):4170-6. DOI: 10.1016/j.biomaterials.2008.07.025. View